The newest therapeutic area for obesity treatment is witnessing considerable buzz with the arrival of SkyBound, a twin -action receptor activator . While Wegovy has previously established itself as a key drug for managing metabolic disorders and weight loss , SkyBound is showcasing remarkable benefits in tests, particularly regarding improved fat l